my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Founded in 2002, PolyTherics is a spin-out company from Imperial College London and the London School of Pharmacy that is dedicated to using biomedical polymers to optimise pharmaceuticals for the diagnosis, treatment and cure of disease. PolyTherics has developed and patented an innovative approa more
PolyTherics Limited, a provider of solutions to enable the development of better biopharmaceuticals, has extended its collaboration with a top five pharmaceutical company to further investigate applications of PolyTherics’ polymer, PolyPEG®. PolyPEG™ is a patented polymer designed to extend the half more
PolyTherics Limited announced that it has formed a research collaboration with Spirogen Limited to develop antibody-drug conjugates (ADCs) that combine PolyTherics’ proprietary site-specific conjugation chemistry with Spirogen’s highly potent novel cytotoxic drugs to produce novel ADCs for the treat more
PolyTherics Limited announced the acquisition of Warwick Effect Polymers (“WEP”), a provider of specialty biopolymers for the modification of biological products. WEP has developed two proprietary biopolymer technologies, PolyPEG® and GlycoPol®, both of which are based on the leading academic work more
Shantha Biotech to launch pentavalent vaccine by'07 (Hyderabad, Pharmabiz -May 16, 2006) Shantha Biotechnics is progressing with its plans to introduce DTP+ Hep B+ Hib pentavalent vaccine by the end of 2006. The company is also in the process of developing a series of new vacci more
Marine Natural Products About us » The Company » Development Programme » Our Team » Company History » Contact us Core technology R & D Pharmaceuticals Consumer Health News Contact us Management | Our Team CEO Professor Simon G Best OBE FRSE Professor Simon Best has over 25 years experience across th more
Biologics OligoMedicines News Investors Extranet Avecia > News News Avecia launches Toolkit for production of Antibody Fragments Date: 13/05/2009 Avecia Biologics has announced it has created a ‘toolkit’ of technologies to meet the production challenges for the next generation of antibody-based ther more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
